Last updated on December 2019

A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin Once a Day


Brief description of study

The study compares 2 medicines for children who do not have enough hormone to grow: somapacitan given once a week (a new medicine) and Norditropin given once a day (the medicine doctors can already prescribe). Researchers will test to see how well somapacitan works. The study will also test if somapacitan is safe. Participants will either get somapacitan or Norditropin - which treatment participants get, is decided by chance. Both participants and the study doctor will know which treatment participants get. The study will last for 4 years. Participants will attend 19 clinic visits and have 1 phone call with the study doctor.

Clinical Study Identifier: NCT03811535

Find a site near you

Start Over

Novo Nordisk Investigational Site

Oklahoma City, OK United States
  Connect »

Novo Nordisk Investigational Site

Fukuyama-shi, Hiroshima, Japan
  Connect »

Novo Nordisk Investigational Site

Rostov-on-Don, Russian Federation
  Connect »

Novo Nordisk Investigational Site

Saint-Petersburg, Russian Federation
  Connect »

Novo Nordisk Investigational Site

Seongnam-si, Gyeonggi-do, Korea, Republic of
  Connect »

Novo Nordisk Investigational Site

Indianapolis, IN United States
  Connect »

Novo Nordisk Investigational Site

Los Angeles, CA United States
  Connect »

Novo Nordisk Investigational Site

Kansas City, MO United States
  Connect »